J David Warren

USPTO Granted Patents = 7 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

Sloan-kettering Institute for Cancer Research

patents

Years Active: 2009-2020

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10617683 - Inhibitors of CRL4 ubiquitin ligase and uses thereof (2020-04-14),

2. 10124019 - Compositions and their use for removing cholesterol (2018-11-13),

3. 9849196 - Methods and compositions for altering photophysical properties of fluorophores via proximal quenching (2017-12-26),

4. 9631096 - Dye compositions, methods of preparation, conjugates thereof, and methods of use (2017-04-25),

5. 8945515 - Methods and compositions for altering photophysical properties of fluorophores via proximal quenching (2015-02-03),

6. 8754192 - Compositions comprising homogeneously glycosylated erythropoietin (2014-06-17),

7. 7635750 - Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation (2009-12-22),

Title: J David Warren: Innovator in Cancer Research and Cholesterol Removal

Introduction

J David Warren, an accomplished inventor based in New York, NY, holds an impressive portfolio of seven patents. His work predominantly revolves around innovative methods for treating cancer and addressing elevated cholesterol levels in mammals.

Latest Patents

Among his latest contributions to the field is a patent titled "Inhibitors of CRL4 Ubiquitin Ligase and Uses Thereof." This invention provides groundbreaking methods for treating cancer by administering a specific small molecule that interferes with the activity of CUL4A. Notable compounds involved include 1,3-benzoxathiol-2-one and 1,2,4-triazole-3-thiol, which significantly aid in increasing DNA repair activity in animals. Another significant patent focuses on "Compositions and Their Use for Removing Cholesterol." This invention outlines a composition designed to treat high cholesterol levels through a polysaccharide linked to cyclic oligosaccharides, and it includes cell-targeting agents for effective treatment.

Career Highlights

J David Warren has significantly impacted research through his work at esteemed institutions such as Cornell University and the Sloan Kettering Institute for Cancer Research. His expertise in scientific research has led him to develop innovative solutions that address critical health issues.

Collaborations

Throughout his career, Warren has collaborated with renowned colleagues, including Scott C Blanchard and Roger Altman. These partnerships have bolstered his research and contributed to the advancement of innovative medical therapies.

Conclusion

J David Warren's contributions to the fields of cancer treatment and cholesterol management through his innovative patents signify a strong commitment to improving health outcomes. His work exemplifies the impact of research and development in addressing pressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.